SUBSCRIBE TO zuNEWS E-NEWSLETTER


zuChem Announces Appointment of Dan Cummings as Chief Operating Officer & General Counsel

Chicago, IL (July 24, 2017) – zuChem, Inc., an innovative supplier of glycochemicals and specialized sugars for the food ingredients, fine chemicals, and related industries, today announced the appointment of Dan Cummings as Chief Operating Officer (COO) and General Counsel. In his role at zuChem, Mr. Cummings will particularly be responsible for overseeing the Company’s […]

Chicago, IL (July 24, 2017) – zuChem, Inc., an innovative supplier of glycochemicals and specialized sugars for the food ingredients, fine chemicals, and related industries, today announced the appointment of Dan Cummings as Chief Operating Officer (COO) and General Counsel.

In his role at zuChem, Mr. Cummings will particularly be responsible for overseeing the Company’s efforts surrounding the manufacturing and commercialization of its xylitol product. Mr. Cummings will also be managing legal functions of the Company and be an integral part of the zuChem executive team.

Commenting, CEO David Demirjian said, “I am pleased to welcome Dan as COO. In his prior positions in biofuels, biochemicals and renewables industries, Dan has proven himself a key member of leadership teams. His deep background and experience will be key factors in our future success as we launch our commercial manufacturing and business operations. Dan’s arrival at zuChem will help ensure a successful launch of our first large-scale product, xylitol, later this year.”

“I am very excited to join zuChem at this exciting phase as we launch our first manufacturing venture for xylitol with a joint venture in China and bring product to market later this year”, added Cummings. “zuChem has outstanding technologies contributing to the human health, nutrition and pharmaceutical space and I look forward to further expanding our manufacturing, partnering and licensing capabilities to drive growth and future market success. “

Mr. Cummings joins zuChem after serving most recently as Founder and CEO of Guidewire Strategies, a renewable energy strategic venturing and consulting firm. Previously, he served as President of POET-DSM and as President and Director of INEOS Bio’s JV. He also held senior business, corporate and legal positions at INEOS and BP. Mr. Cummings holds a Law Degree from Temple University, a Master of Public Administration from the University of Southern California and a Bachelor in Economics from the University of Puget Sound.

About zuChem, Inc.
zuChem, Inc., headquartered in Chicago, Illinois, develops and commercializes innovative green manufacturing processes to produce unique carbohydrates and glycochemicals (varieties of specialized sugars) important for human health and nutrition. The Company’s proprietary technology platform allows it to inexpensively produce a variety of specialty sweeteners, pharmaceutical intermediates, nutritional prebiotics and other bioproducts at industrial scale using renewable chemicals as raw materials. Please visit www.zuchem.com or contact info@zuchem.com for more information.


zuChem Expands zuCarb Products Line, Adds to Management Team

Chicago, IL (July 7, 2015) – zuChem, Inc., an innovative supplier of glycochemicals and specialized sugars for the food ingredients, fine chemicals and related industries, today announced the release of its new 2015 zuCarb Research Products Catalog. The catalog offers an expanded array of rare sugars, including activated sugars, for use in pharmaceutical, nutritional and […]

Chicago, IL (July 7, 2015) – zuChem, Inc., an innovative supplier of glycochemicals and specialized sugars for the food ingredients, fine chemicals and related industries, today announced the release of its new 2015 zuCarb Research Products Catalog. The catalog offers an expanded array of rare sugars, including activated sugars, for use in pharmaceutical, nutritional and other life science research and development applications. In related news, zuChem also announced the addition of Bob Gonzalez to its management team. Mr. Gonzalez will be responsible for commercial development of the Company’s zuCarb products line, reporting to CEO David Demirjian.

“I am pleased to welcome Bob Gonzalez to the zuChem team. In his new capacity, Bob will be responsible for expanding sales, marketing and customer support of our zuCarb product line. These rare sugar products provide researchers with new biochemical tools to accelerate their research and expand new approaches to improving disease management and health,” commented Dr. Demirjian.

Mr. Gonzalez brings more than fifteen years of broad business development experience in the health and nutrition industry to his role at zuChem. Most recently he co-founded start-up Hearts & Minds LLC, a specialty food company offering health conscious consumers the foods they love to eat made better for them. He was also co-founder and CEO of NewNeural LLC, a biotechnology company that developed technologies licensed from University of Illinois to treat diseases and injuries of the central nervous system. He has previously held commercial development positions at Ingredion (formerly Corn Products) and Monsanto. Mr. Gonzalez holds a Bachelor of Science degree in Chemical Engineering from Purdue University, and earned a Master of Business Administration in Finance from The University of Chicago Booth School of Business.

About zuChem, Inc.

zuChem, Inc., headquartered in Chicago, Illinois, develops and commercializes innovative green manufacturing processes to produce unique carbohydrates and glycochemicals (varieties of specialized sugars) important for human health and nutrition. The Company’s proprietary technology platform allows it to inexpensively produce a diverse array of specialty sweeteners, pharmaceutical intermediates, nutritional prebiotics and other bio-products at industrial scale using renewable chemicals as raw materials. A copy of the 2015 zuCarb Research Products Catalog may be obtained by emailing zucarb@zuchem.com. For more information on zuChem please contact info@zuchem.com or visit www.zuchem.com.


zuChem Announces Appointment of Jeffrey Whitnell as Chief Financial Officer

Chicago, IL (May 27, 2015) – zuChem, Inc., an innovative supplier of glycochemicals and specialized sugars for the food ingredients, fine chemicals and related industries, today announced the appointment of Jeffrey A. Whitnell as Chief Financial Officer (CFO). In his role at zuChem Mr. Whitnell will oversee the company’s finance operations and be part of the zuChem executive team, […]

Chicago, IL (May 27, 2015) – zuChem, Inc., an innovative supplier of glycochemicals and specialized sugars for the food ingredients, fine chemicals and related industries, today announced the appointment of Jeffrey A. Whitnell as Chief Financial Officer (CFO).

In his role at zuChem Mr. Whitnell will oversee the company’s finance operations and be part of the zuChem executive team, reporting to CEO David Demirjian, Ph.D.

Commenting, David Demirjian said, “I am pleased to welcome Jeff Whitnell as CFO. In his prior positions in the life sciences industry, Jeff has proven himself a key member of leadership teams. His extensive, on-point experience will provide critical strategic oversight as we expand our commercial operations.”

Mr. Whitnell brings more than fifteen years of broad financial experience and leadership in the life sciences industry to his role at zuChem.  He was most recently CFO at ReliefBand Medical Technologies, a Chicago-based medical device company. Prior to ReliefBand, he served as CFO for Akorn, Inc., Vice President of Finance and Treasurer for Ovation Pharmaceuticals, and Vice President of Finance and Treasurer for MediChem Life Sciences.  He currently serves as a Director for Elite Pharmaceuticals, Inc., a publicly traded specialty pharmaceuticals company.  Mr. Whitnell holds a Bachelor of Science in Accounting from the University of Illinois at Urbana-Champaign, is a Certified Public Accountant, and earned a Master of Business Administration in Finance from The University of Chicago Booth School of Business.


zuChem Receives Phase II SBIR Award from the National Institutes of Health

Chicago, IL (April 29, 2015) – zuChem, Inc., an innovative supplier of glycochemicals and specialized sugars for the food ingredients, fine chemicals and related industries, today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant totaling over $1.2MM by the National Institutes of Health (NIH). The grant, entitled “High […]

Chicago, IL (April 29, 2015) – zuChem, Inc., an innovative supplier of glycochemicals and specialized sugars for the food ingredients, fine chemicals and related industries, today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant totaling over $1.2MM by the National Institutes of Health (NIH). The grant, entitled “High yield production of GDP-fucose for fucosylation of molecules,” will support expansion of zuChem’s ongoing programs to develop new cost-effective, scaleable methods to manufacture carbohydrate-based products of interest to the life sciences industry.

“Fucosylation is the process of adding fucose sugar units to a molecule. It is one of the most common sugar modifications found in nature and plays a key role in biological recognition events, including tissue development, cell adhesion, inflammation and tumor metastasis,” explained David Demirjian, Ph.D., President and CEO, zuChem. “Our system to produce l-fucose and custom fucosylated molecules opens up the ability to more easily synthesize a new generation of prebiotics and other nutritional products, as well as a variety of drug candidates for the treatment and prevention of many diseases.”

zuChem has an active program to develop a robust process technology platform for the cost-effective manufacture of a wide variety of fucosylated molecules. Recently zuChem was awarded a Phase II SBIR grant by the NIH to support development of methods to manufacture fucosylated human milk oligosaccharides (HMOs), including 2’-fucosyllactose and 3′-fucosyllactose. HMOs are believed to play important roles in infant cognitive and immune development. This additional Phase II SBIR grant on the production of GDP-fucose will support zuChem’s expansion of its process technology platform in to additional areas of pharmaceutical interest.

About zuChem, Inc.

zuChem, Inc., headquartered in Chicago, Illinois, develops and commercializes innovative green, renewable manufacturing processes to produce unique carbohydrates and glycochemicals (varieties of specialized sugars) for human health and nutrition. The Company’s proprietary technology platform allows it to produce a variety of specialty sweeteners, pharmaceutical intermediates, nutritional prebiotics and other industrial bio-products using enzymatic, fermentation and synthetic biology technologies. Please visit www.zuchem.com or contact info@zuchem.com for more information.


zuChem Receives SBIR Awards from the National Institutes of Health

Novel Technologies Used to More Cost-effectively Produce Key Rare Sugar Intermediates Chicago, IL (December 2, 2014) – zuChem Inc., an innovative supplier of glycochemicals and specialized sugars for the food ingredients, fine chemicals and related industries, today announced that it has been awarded two Small Business Innovation Research (SBIR) grants totaling over $1.25MM by the […]

Novel Technologies Used to More Cost-effectively Produce Key Rare Sugar Intermediates

Chicago, IL (December 2, 2014) – zuChem Inc., an innovative supplier of glycochemicals and specialized sugars for the food ingredients, fine chemicals and related industries, today announced that it has been awarded two Small Business Innovation Research (SBIR) grants totaling over $1.25MM by the National Institutes of Health (NIH) for the development of new technologies to make activated sugars – key building blocks that enable the discovery of new anti-infective and anticancer drugs, as well as the production of important complex glycans such as human milk oligosaccharides.

The Company was awarded a Phase II SBIR on the production of activated TDP-deoxysugars. The award (of approximately $1.1MM) will be used to support zuChem’s continued development of a novel, proprietary system to produce at commercial scale pharmaceutically-relevant activated TDP-deoxysugars that cannot otherwise be made or are currently prohibitively expensive to produce. Activated TDP-sugars are key reagents necessary for the linking of sugars to other molecules and enable the generation of diverse arrays of novel sugar-based chemicals for many applications, including drug discovery and development.

The Company was also awarded a Phase I SBIR from the NIH on the production of activated hexosamines used by zuChem for the production of important oligosaccharides, including human milk oligosaccharides (HMOs). HMOs are key components of human breast milk, but have been difficult to source for study to better understand their role in infant immune and cognitive development.

“We are very pleased that the NIH has recognized the innovative nature of our technology and the significant chemistry bottleneck that the availability of these novel reagents will relieve”, stated David Demirjian, Ph.D., President and CEO, zuChem. “We are finding that our ability to creatively accelerate the development of novel rare sugar reagents is critical to enabling pharmaceutical and biotechnology companies to move forward with the discovery and development of new therapeutic agents and nutritionals.”

zuChem, Inc., headquartered in Chicago, Illinois, focuses on commercializing innovative manufacturing processes for unique glycochemicals (varieties of specialized sugars) for the pharmaceutical and specialty chemicals industries. Glycochemicals are key components of many antibiotics, anticancer and antiviral drugs as well as many specialty food ingredients. Please visit www.zuChem.com or contact info@zuChem.com for more information.


zuChem Enters in to Exclusive License for Rights to 2’-FL Production Technology

Chicago, IL (January 21, 2014) – zuChem, Inc., an innovative supplier of carbohydrates, specialized sugars, and process technology for the food, nutritional, and pharmaceutical related industries, today announced that it has entered into a global licensing agreement with the University of Illinois at Urbana-Champaign for rights to a novel method for the production of 2′-fucosyllactose […]

Chicago, IL (January 21, 2014) – zuChem, Inc., an innovative supplier of carbohydrates, specialized sugars, and process technology for the food, nutritional, and pharmaceutical related industries, today announced that it has entered into a global licensing agreement with the University of Illinois at Urbana-Champaign for rights to a novel method for the production of 2′-fucosyllactose (2’-FL). 2’-FL is the most abundant human milk oligosaccharide (HMO) in breast milk and thought to have a variety of health benefits, including protection from enteric pathogens and assisting in cognitive development.

“zuChem is the right partner for the commercialization of this technology,” said Lesley Millar-Nicholson, director of the University’s Office of Technology Management. “The Company has developed scalable processes to manufacture new nutritional and health carbohydrates and is well positioned to expand upon work developed here on the Urbana campus and implement it at the commercial scale and cost necessary to bring 2’-FL to market.”

“We are excited to be adding the 2’-FL production technology developed by Drs. Jin, Miller, and their coworkers to our oligosaccharide production platform,” said David Demirjian, CEO of zuChem. “This technology is an excellent fit for our Company and allows us to expand our product offerings in this important area. Fucosylated oligosaccharides such as 2’-FL have been traditionally difficult to make and in the short term we expect this new product to assist researchers in investigating the biological role of 2’-FL.”

zuChem has been developing a robust process technology platform for the cost-effective manufacture of a wide variety of oligosaccharides, including HMOs such as 2’-FL and others. Recently the Company was awarded a Phase I Small Business Innovative Research (SBIR) Grant by the National Institutes of Health to support development of fucosylated oligosaccharides and their precursors, including 2’-FL (Dr. Leila Aminova, Principal Investigator). The University’s 2’-FL technology directly complements Dr. Aminova’s work.

zuChem is currently in the process of optimizing and scaling its oligosaccharide production technology. The technology will made available for large-scale use through strategic partnerships with interested parties. In addition, the 2’-FL product will also be made available in research quantities as part of the Company’s expansion of its zuCarb™ Reagents products catalog. This catalog is focused on meeting the increasing demand for rare and modified sugars, and the reagents necessary for their use by researchers. New products launched in 2013 include rare sugars such as l-galactose, as well as sugar phosphates including β- l-glucose-1-phosphate, α-d-galactose-1-phosphate and β-l-xylose-1-phosphate. Additional new products available include a variety of activated sugars, available on a custom order basis. For additional information on the availability of 2’-FL and other products, please contact zuChem at (312) 997-2150 or info@zuchem.com.

 

About the University of Illinois at Urbana-Champaign

The University of Illinois at Urbana-Champaign is a world-class research institution boasting a respected faculty, high national rankings, and state-of-the-art facilities. The University’s accomplishments include 22 Nobel Laureates among its faculty and alumni and such revolutionary innovations as the Web browser, new plant varieties, and even the discovery of a third form of life.

 

About zuChem, Inc.

zuChem develops and commercializes innovative green, renewable manufacturing processes to produce unique carbohydrates and glycochemicals for human health and nutrition. The Company’s proprietary technology platform allows it to produce a variety of specialty sweeteners, pharmaceutical intermediates, nutritional prebiotics and other industrial bio-products using enzymatic, fermentation and synthetic biology technologies. zuChem is headquartered in Chicago, Illinois with research operations in Peoria, Illinois. For more information on zuChem’s proprietary rare sugar manufacturing processes and the availability of its food ingredient, specialty chemical and pharmaceutical intermediate products, please visit www.zuchem.com or call Rajni Aneja at (312) 997-2150.


Zuchem Expands Rare Sugar Product Offerings

Chicago, IL (September 9, 2013) – zuChem, Inc., an innovative supplier of glycochemicals and other specialized sugars for the pharmaceutical, food and related industries, today announced the expansion of its zuCarbTM products catalog. This catalog expansion is part of zuChem’s commitment to meeting increasing demand for rare and modified sugars, and the reagents necessary for

Chicago, IL (September 9, 2013) – zuChem, Inc., an innovative supplier of glycochemicals and other specialized sugars for the pharmaceutical, food and related industries, today announced the expansion of its zuCarbTM products catalog. This catalog expansion is part of zuChem’s commitment to meeting increasing demand for rare and modified sugars, and the reagents necessary for their use in synthetic carbohydrate chemistry applications. New products available include rare sugars such as l-galactose, as well as sugar phosphates including β-l-glucose-1-phosphate, α-d-galactose-1-phosphate and β-l-xylose-1-phosphate. Additional new products available include a variety of activated sugars, available on a custom order basis.

zuChem scientists will also be presenting technical updates on continuing product development programs at the 246th American Chemical Society National Meeting & Exposition in Indianapolis from September 8 – 12, 2013. Dr. Leila Aminova will present a paper entitled “Production and scale-up of oligosaccharides using an engineered enzyme system”, and Dr. Micah Shepherd will be presenting “Engineered Escherichia coli for the production of TDP-deoxysugars” in the ACS Carbohydrate Division session being held on September 10, 2013. Both papers highlight recent advances by zuChem scientists towards providing innovative biosynthetic methods to solve supply challenges for rare and expensive carbohydrate building blocks.

For more information on zuChem’s zuCarbTM product offerings, including an updated 2013 catalog, and custom synthesis services, please email info@zuchem.com or call (312) 997-2150.

About zuChem, Inc.

zuChem, based in Chicago, Illinois, is focused on commercializing innovative manufacturing processes to provide unique glycochemicals (varieties of specialized sugars) for the pharmaceutical, food and specialty chemicals industries. The company provides both “off-the-shelf” availability and custom synthesis of a wide variety of molecules, including rare l-sugar derivatives and other unusual glycochemicals. The company’s fully staffed research facilities, located in Peoria, Illinois, are equipped for small molecule glycosylation, microbial fermentation, biotransformation, as well as other focused services. More information is available at www.zuchem.com or by calling (312) 997-2150.


zuChem Receives Two Polyol Patents

zuChem announced today that the United States Patent and Trademark office has recently issued 2 patents

Chicago, IL (June 17, 2013) – zuChem Inc., a leading producer of unique carbohydrates for human health and nutrition, announced today that the United States Patent and Trademark office has recently issued 2 patents – US 8,367,346 entitled “Methods for Production of Xylitol in Microorganisms”, and US 8,338,147 entitled “Process for producing D-Mannitol”. These two patents expand zuChem’s technology portfolio for the fermentative production of natural food sweetener products from abundant, renewable feedstocks.

The xylitol technology was developed by zuChem in collaboration with the U.S. Department of Agriculture, Agricultural Research Service’s National Center for Agricultural Utilization Research and the Biotechnology Research and Development Corporation (BRDC) under a Cooperative Research and Development Agreement. zuChem is the exclusive licensee of this patent under its relationship with the BRDC, to whom this patent is assigned. The mannitol technology was acquired from Hydrios Biotechnology Ltd. of Helsinki, Finland as part of a portfolio of patents developed by Hydrios and the Laboratory of Bioprocess Engineering at Helsinki University of Technology. This technology is now an important component of zuChem’s fermentative mannitol process, which has been approved by the FDA as a safe and effective method for the production of mannitol.

Xylitol and mannitol belong to a class of specialty sweeteners called polyols, and have traditionally been produced from by chemical hydrogenation. The demand for these sweeteners is on the rise because of their unique health properties and growing demand in products such as gum, candy, beverages, diabetic foods and other sugar-free confectionery products. zuChem’s processes are natural fermentative alternatives to the chemical process and utilize readily available biomass as feedstocks.

“We are very pleased by this addition to our intellectual property portfolio on novel biosynthetic production processes of both xylitol and mannitol,” David Demirjian, Ph.D., President and CEO, zuChem. “Our xylitol process is now in scale-up with our first commercial manufacturing partner and we hope to have product on the market in 2014” Dr. Demirjian is slated to give a presentation of the xylitol process at the World Congress on Industrial Biotechnology on June 17th in Montreal, Canada.

About zuChem, Inc.

zuChem focuses on commercializing innovative manufacturing processes for unique specialized carbohydrates for the food, fine chemicals and pharmaceutical intermediates industries. These specialized carbohydrates are key components of many drugs and drug candidates as well as many specialty food ingredients. The company is headquartered in Chicago, IL, with research operations in Peoria, IL. For more information on zuChem’s xylitol manufacturing process and the availability of other specialty chemicals processes, please contact:

Rajni Aneja
info@zuChem.com
2225 W. Harrison, Suite F
Chicago, IL 60612
Tel: (312) 997-2150


zuChem and Godavari Partner to Commercialize Renewable Manufacturing Bioprocess for Xylitol

zuChem Inc. and Godavari Biorefineries Ltd. announced today that they have entered into a global partnership

CHICAGO, IL and MUMBAI, INDIA (February 11, 2013) – zuChem Inc. and Godavari Biorefineries Ltd. announced today that they have entered into a global partnership combining zuChem’s xylitol technology platform with Godavari’s leadership position in the production and commercialization of sweeteners and renewable sugar-derived ingredients. Under the agreement, the parties will apply zuChem’s proprietary bioprocess technology to produce a bio-sourced xylitol for use as a food ingredient. Godavari is an established producer and marketer of sugar and sugar-derived renewable materials since 1939, with a commitment to providing renewable ingredients to the global food ingredients industry.

“Our partnership with zuChem enables us to expand our sweeteners product portfolio while continuing to build on our biorefinery model, under which we convert otherwise waste biomass components into high value-added renewable ingredients, such as xylitol,” said Samir Somaiya, Chairman and Managing Director of Godavari Biorefineries Ltd.

“We are thrilled to be working with Godavari to deliver this new xylitol product to the market. Godavari is one of the true biorefinery innovators, and we are proud to see our process integrated into their facility,” said David Demirjian, CEO of zuChem.

Xylitol is a naturally occurring sweetener, contributing about 30% fewer calories than sucrose. In contrast to other sweeteners, xylitol has been shown to be actively beneficial for dental health, significantly reducing the occurrence of dental caries with regular use. It has also been shown to reduce the incidence of ear and upper respiratory infections and can be used as a diabetic sweetener.

Xylitol is primarily used by the confectionary and dental hygiene industries, and is considered the sweetener of choice in sugar-free gums in Asia and Europe. It has been gaining in popularity in the US and North America, but is subject to availability issues and price variability due to shortages of the current raw material used for its manufacture by chemical hydrogenation. The zuChem bioprocess process alleviates these constraints and, combined with Godavari’s production capabilities, will open the market for the development of new xylitol-containing products.

About zuChem Inc.
zuChem develops and commercializes innovative green, renewable manufacturing processes to produce unique carbohydrates and glycochemicals for human health and nutrition. The Company’s proprietary technology platform allows it to produce a variety of specialty sweeteners, pharmaceutical intermediates, nutritional prebiotics and other industrial bioproducts using enzymatic, fermentation and synthetic biology technologies. zuChem is headquartered in Chicago, Illinois with research operations in Peoria, Illinois. For more information on zuChem’s proprietary rare sugar manufacturing processes and the availability of other food ingredients, specialty chemicals and pharmaceutical intermediates, please visit www.zuchem.com or call (312) 997-2150.

About Godavari Biorefineries Ltd.
Godavari Sugar Mills Ltd. was incorporated in 1939, and in 2009 Godavari Biorefineries Ltd. was established to emphasize Godavari’s expanding focus on renewable products from sugarcane. A part of the Somaiya Group, Godavari is a fully integrated sugar and biofuels producer, and is ranked among the top ten sugar manufacturers in India. Godavari is also one of the largest producers of bioethanol and a pioneer in manufacture of alcohol-based chemicals in India. For more information on Godavari and the Somaiya Group, please visit www.somaiya.com or call the company’s U.S. headquarters at (607) 319-5016.

This technology was developed in collaboration with researchers at the US Department of Agriculture and the University of Illinois. Funding for its development was provided in part by the Biotechnology Research and Development Corporation, the US Department of Energy, and the National Science Foundation.


Alliance Formed Between zuChem Inc and Austin Chemical Company Inc

zuChem Inc. and Austin Chemical Company, Inc. announced today that they have formed an alliance for Austin Chemical to market and sell zuChem-produced rare sugars produced under its zuCarb™ product line worldwide.

Chicago, Illinois. December 9, 2008. zuChem Inc. and Austin Chemical Company, Inc. announced today that they have formed an alliance for Austin Chemical to market and sell zuChem-produced rare sugars produced under its zuCarb™ product line worldwide. Under the terms of the alliance, Austin will represent both zuChem’s product and custom synthesis service offerings to the fine chemicals and pharmaceuticals industry.

“We are very excited to have Austin as our sales and marketing partner,” commented David Demirjian, Ph.D. zuChem’s CEO.  “Austin’s reputation and its long history of success in the fine chemicals and pharmaceutical market will have a significant impact in expanding the customer base for our rare sugar products .”

“zuChem’s rare sugar products such as L-ribose and others are a great fit for our portfolio and are in growing demand by pharmaceutical companies.  zuChem has developed breakthrough cost effective processes that give these products a significant competitive price advantage and we look forward to working with zuChem to make these products more widely available,” said Samuel M. Ponticelli, Chairman & CEO of Austin Chemical.

Austin will be exhibiting at INFORMEX in San Francisco January 27th – 30th, 2009 where it will be introducing new additions to zuChem’s 2009 zuCarb™ product line.

About Austin Chemical Company Inc. 
Austin Chemical is a leading information, services, and products provider to the health sciences and specialty fine chemicals industries.   Austin Chemical’s service products such as sales and marketing, sourcing and procurement, logistics support, distribution, and market investigation have been created to support its suppliers’ and customers’ needs as an asset extension. The company is based in Buffalo Grove, Illinois. For more information on products and services offered by Austin, including the zuCarb™ product line, please email info@austinchemical.com or call (847) 520-9600.

About zuChem Inc. 
zuChem focuses on commercializing innovative manufacturing processes for unique glycochemicals (varieties of specialized sugars) for the food, fine chemicals and pharmaceutical intermediates industries. Glycochemicals are key components of many drugs and drug candidates as well as many specialty food ingredients.   The company is based in Chicago, Illinois and has research operations in Peoria, Illinois.  For more information on zuChem’s rare sugar manufacturing processes and the availability of other specialty chemicals, please email info@zuchem.com or call (312) 997-2150.